stockrow
Friday 6 November 2026
Export NHC’s income statement to Excel — free account
National HealthCare Corporation
NHC Healthcare Medical Care Facilities
National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.
- Revenue
- +6.61%
- EPS
- −65.6%
- Free cash flow
- +75.5%
- Total debt
- +216.7%
Quarter to September 2026, against a year earlier
207.47
4.93
−2.32%
Follow NHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
11.67% | 11.75% | 13.03% | 10.47% | |
Piotroski F-Score |
7 | 6 | 7 | 4 | |
| 7.87% | 8.05% | 9.05% | 6.30% | ||
ROIC |
10.38% | 10.34% | 10.49% | 0.00% | |
Return on Tangible Assets |
13.61% | 13.95% | 15.08% | 8.04% | |
Average Days of Receivables |
33.43 | 32.95 | 32.24 | 29.89 | |
Free Cash Flow per Share |
9.61 | 10.84 | 9.38 | 14.18 | |
Free Cash Flow |
148.63 | 168.41 | 146.53 | 221.76 | |
Capital Expenditures |
(36.45) | (39.95) | (42.27) | — | |
| Other line items | |||||
Cash ROIC |
10.68% | 11.96% | 10.51% | 19.20% | |
Accounts Receivable Turnover |
11.07 | 10.92 | 11.15 | 12.09 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.23) | (0.23) | (0.23) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
85.54% | 85.46% | 84.79% | 84.80% | |
Share Based Compensation of Revenue |
0.29% | 0.30% | 0.35% | 0.39% | |
Interest Coverage |
20.15 | 28.64 | 56.65 | 0.00 | |
Operating CF/Net income |
1.54 | 1.68 | 1.35 | 1.93 | |
Depreciation/Fixed assets |
0.07 | 0.07 | 0.06 | 0.04 | |
Capex/Depreciation |
(0.81) | (0.88) | (0.92) | 0.00 | |
Revenue per Share |
98.10 | 98.18 | 99.82 | 101.31 | |
Operating CF per Share |
11.96 | 13.41 | 12.09 | 14.18 | |
Capex per Share |
(2.36) | (2.57) | (2.71) | 0.00 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026